Oklahoma City GLP-1 RA Litigation Attorneys 

Legal Support for Individuals Suffering Weight Loss Drugs Side Effects 

Touted as life-changing solutions for weight loss and diabetes management, GLP-1 receptor agonist (GLP-1 RA) medications, such as Ozempic and Wegovy, have made a dramatic impact. In Oklahoma, bariatric clinics are shutting down as patients turn to these medications. Nationwide, approximately 1 in 8 adults — millions of people — have used these medications.

Yet, lurking behind the promise is a growing concern. A rising number of individuals have reported serious side effects, with the most severe cases leading to permanent consequences. These lasting impacts have profoundly altered the lives of those who were meant to be helped.

Our team is committed to standing by Oklahoma residents harmed by these medications. We understand how daunting it feels to go toe-to-toe with large pharmaceutical companies, but you don’t have to fight this battle alone. You deserve an ally who empathizes with your situation and has the tools to hold manufacturers accountable for failing to warn about dangerous side effects. 

Experiencing severe health issues linked to GLP-1 medications? Call (405) 433-7414 or contact us now for a free, no-obligation consultation.

Breakthrough Medications or Dangerous Gamble: What Are GLP-1 RAs? 

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as Ozempic, Mounjaro, and Wegovy, are a class of medications initially developed to help manage Type 2 diabetes. By mimicking the hormone glucagon-like peptide-1, these drugs stimulate insulin production and slow digestion, effectively reducing blood sugar spikes.

Over time, researchers discovered another effect of GLP-1s: appetite suppression. This catapulted the drugs into the weight-loss market, with pharmaceutical companies developing higher-dosage versions for patients seeking to manage obesity. 

Marketed under names like Ozempic, Wegovy, and Mounjaro, these medications quickly gained traction. Celebrities flaunting their success with these “miracle drugs” and social media buzz created a surge in demand. Wegovy received FDA approval for chronic weight management in 2021, opening the floodgates for millions of Americans to obtain prescriptions.

It wasn’t long before patients began reporting adverse effects. Gastrointestinal issues like nausea, vomiting, and diarrhea were listed as common side effects on the drugs’ labels, but more concerning conditions began to emerge.

GLP-1 RAs and Your Health: Side Effects & Emerging Risks 

While many people use GLP-1 RAs without serious complications, it is increasingly evident that these medications are not risk-free. Gastrointestinal issues are the most common, with over half of patients reporting nausea during a clinical trial. About one-third experienced vomiting, and many others faced diarrhea, constipation, and abdominal pain. 

But these symptoms are only the beginning. Emerging research and patient reports have identified more severe risks, including gastroparesis (paralysis of the stomach). This condition prevents the stomach from properly emptying its contents, often leading to chronic nausea, vomiting, malnutrition, and significant weight loss. Severe cases may require hospitalization or surgery.

Other concerning risks include intestinal blockages, pancreatitis, and rare but severe gallbladder complications such as cholecystitis (inflammation). Vision-related complications and deep vein thrombosis have also been reported in some instances.

Compounding these risks is the fact that long-term effects remain largely unknown, as millions of people are still in the early stages of taking these medications. 

If you’re struggling with symptoms such as chronic vomiting, persistent abdominal pain, or unexplained weight loss, you could be experiencing side effects from a GLP-1 drug. 

Legal Grounds for Filing a GLP-1 RA Lawsuit 

Pharmaceutical companies have a duty to test their products thoroughly and inform consumers about any risks associated with their use. Unfortunately, the companies behind GLP-1 RAs may have failed in this responsibility. Product liability lawsuits related to these drugs are typically based on several key claims:

• Negligence: Failure to exercise proper caution in testing and manufacturing. 
• Failure to Warn: Many GLP-1 RA drugs, like Ozempic and Mounjaro, list vague warnings about potential gastrointestinal problems but fail to explicitly mention severe risks like gastroparesis or bowel obstruction. 
• Defective Design: Allegations that the drugs’ formula contributed to the adverse effects experienced by users. 

The first multi-district litigation (MDL) for GLP-1 RAs was recently established to address the growing number of claims. Known as MDL 3094, this litigation consolidates cases alleging that manufacturers failed to adequately disclose serious risks tied to their medications. 

These legal developments illustrate a critical opportunity for victims to seek justice and compensation. However, navigating product liability cases is complex and requires in-depth knowledge of both medical evidence and legal precedents. 

If GLP-1 drugs have left you suffering, we’re here to help. Call (405) 433-7414 or contact us online to schedule your free consultation and protect your rights.

Most Popular GLP-1 Receptor Agonists on the Market

Ozempic is a GLP-1 medication developed by Novo Nordisk. Primarily prescribed for managing Type 2 diabetes, it has since gained extensive off-label use as a weight-loss medication. Common side effects include nausea, vomiting, and diarrhea, but more severe complications, such as gastroparesis and gallbladder disease, have also been reported.

Wegovy, also manufactured by Novo Nordisk, was FDA-approved in 2021 specifically for chronic weight management. It shares many of the same side effects as Ozempic, including persistent nausea, gastrointestinal discomfort, and potential risks to gallbladder health.

Rybelsus, another product from Novo Nordisk, offers an oral option for GLP-1 therapy. While it eliminates the need for injections, it does not escape the side effects common to its drug class. Patients often report symptoms like nausea and diarrhea, with emerging evidence pointing to potential risks of more severe gastrointestinal complications.

Trulicity, produced by Eli Lilly, plays a dual role in managing Type 2 diabetes by controlling blood sugar spikes and mitigating the risk of heart disease. Like its counterparts, Trulicity often triggers nausea and intestinal issues as side effects.

Mounjaro, also from Eli Lilly, is a newer GLP-1 medication that combines two hormone-like mechanisms for enhanced blood sugar control and weight management. Its formulation has proven effective for many patients, but it is accompanied by severe gastrointestinal problems in some cases.

Do You Have a Case Against GLP-1 RA Manufacturers?

If you’ve suffered severe side effects after using a GLP-1 medication, you may wonder if you qualify for legal action. To build a strong case, consider the following factors:

• Prescription History. You must have proof that you were prescribed and used a GLP-1 RA medication. 
• Severe Side Effects. Have you been diagnosed with a condition like gastroparesis, bowel obstruction, or gallbladder disease? 
• Medical Records. Your severe side effects should be documented in your medical records. It is helpful if your documentation should link your side effects to your use of the medication. 
• Timeline.  Your condition must have developed after you began taking the drug. 

During a free consultation, our team can evaluate the specifics of your situation and advise you on the strength of your claim. 

Steps to Take If You’ve Been Harmed by GLP-1 RAs 

If you believe a GLP-1 RA drug harmed you, it’s essential to act quickly. Begin by taking the following steps:

1. Seek Medical Attention. If you experience severe symptoms, consult your healthcare provider immediately to ensure you receive proper care. 
2. Document Everything. Gather your prescription information, medical records, and any symptoms you’ve experienced. Journaling your physical and emotional challenges can also be valuable evidence. 
3. Avoid Discussing Your Case. Be cautious about sharing your experience on social media or with the pharmaceutical company before consulting a lawyer. 
4. Contact a Trusted Legal Team. Working with a knowledgeable attorney increases your chances of holding manufacturers accountable. 

We Will Stand with You Against GLP-1 RA Manufacturers 

Empowering injured people is not just our mission; it’s our promise. When powerful pharmaceutical corporations endanger the public, they must be held accountable. At our firm, we are dedicated to helping victims fight for the justice and compensation they deserve. With over 30 years of experience handling more than 2,500 cases, we provide comprehensive and compassionate legal support. 

Our process starts with a free, confidential consultation, and we operate on a contingency fee basis, meaning you won’t pay legal fees unless we secure compensation on your behalf. Additionally, we offer bilingual services in English and Spanish and are available 24/7 to assist you whenever you need us. 

If you’ve been harmed by GLP-1 medications like Ozempic or Wegovy, call (405) 433-7414 or contact us online to take the first step toward justice.